Given the lower levels of HbA1c in G6PD carriers with a T2D diagnosis which could lead to delays in treatment escalation, we sought to investigate the effect of G6PD deficiency allele carrier status on diabetes complications. This evidence concerns the gene G6PD and diabetes mellitus.